All In MedTech

FDA Clearance Tracker · K222002

Persyst 15 EEG Review and Analysis Software

A 510(k) clearance means FDA found the device substantially equivalent to one already on the market. It is not an approval, and it is not a finding that the device works better than others.

Last checked: Nov 19, 2026Latest source record: Dec 30, 2022 (this decision)Source: openFDAMethods & limitations

510(k)

Decided

Dec 30, 2022

Substantially Equivalent

Time to decision

176 days

Received Jul 7, 2022. Calendar days, including time FDA spent waiting on the applicant.

Pathway

510(k)

Traditional

Device class

Class II

The decision

FDA number
K222002
Device name
Persyst 15 EEG Review and Analysis Software
Applicant location
Solana Beach, CA
Received
Jul 7, 2022
Decided
Dec 30, 2022
Decision
Substantially Equivalent
Submission type
Traditional

Device type

Device class
Class II
Regulation
21 CFR 882.1400

Every decision under product code OMB

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code OMB. The earliest in FDA's data is K870450, decided Apr 8, 1987.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

  • FDA database record for K222002
  • The applicant filed a statement instead of a public summary, or the summary is not at FDA's usual address. Check the FDA record.

The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.

Other decisions for Persyst Development Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.